Search research articles
Contact Us
Filters
Showing results (71-80 of 568) with videos related to
Page
of 57
Sort By:
Journal of Medicinal Chemistry
|
February 1, 1990
Potential antisecretory antidiarrheals. 2. Alpha 2-adrenergic 2-[(aryloxy)alkyl]imidazolines
A E Moormann, B S Pitzele, P H Jones, et al.
Cancer Gene Therapy
|
May 10, 2008
In vivo persistence of genetically modified T cells generated ex vivo using the fibronectin CH296 stimulation method
S S Yu, I Nukaya, T Enoki, et al.
Journal of Applied Microbiology
|
June 12, 2019
Immune efficacy of a porcine circovirus type 2 vaccine purified using Gram-positive enhancer matrix surface display technology
X-W Qiao, X-M Yu, P-C Li, et al.
Gene Therapy
|
July 15, 2003
Electro-gene therapy of collagen-induced arthritis by using an expression plasmid for the soluble p75 tumor necrosis factor receptor-Fc fusion protein
J-M Kim, S-H Ho, W Hahn, et al.
Agents and Actions
|
January 1, 1993
The design and synthesis of second generation leukotriene B4 (LTB4) receptor antagonists related to SC-41930
T D Penning, S W Djuric, S H Docter, et al.
Mayo Clinic Proceedings
|
November 24, 1999
Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial
W G Bensen, J J Fiechtner, J I McMillen, et al.
JAMA
|
December 2, 1999
Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial
L S Simon, A L Weaver, D Y Graham, et al.
Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics
|
January 23, 2025
[Short-term efficacy of rituximab in children with calcineurin inhibitor resistant steroid resistant nephrotic syndrome]
S S Yu, J L Liu, J J Liu, et al.
Physical Review Letters
|
December 31, 2005
Drift compression of an intense neutralized ion beam
P K Roy, S S Yu, E Henestroza, et al.
Journal of Medicinal Chemistry
|
April 25, 1997
Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib)
T D Penning, J J Talley, S R Bertenshaw, et al.
Page
of 57
Search research articles
Search
Showing results (71-80 of 568) with videos related to
Sort By:
Page
of 57
Journal of Medicinal Chemistry
|
February 1, 1990
Potential antisecretory antidiarrheals. 2. Alpha 2-adrenergic 2-[(aryloxy)alkyl]imidazolines
A E Moormann, B S Pitzele, P H Jones, et al.
Cancer Gene Therapy
|
May 10, 2008
In vivo persistence of genetically modified T cells generated ex vivo using the fibronectin CH296 stimulation method
S S Yu, I Nukaya, T Enoki, et al.
Journal of Applied Microbiology
|
June 12, 2019
Immune efficacy of a porcine circovirus type 2 vaccine purified using Gram-positive enhancer matrix surface display technology
X-W Qiao, X-M Yu, P-C Li, et al.
Gene Therapy
|
July 15, 2003
Electro-gene therapy of collagen-induced arthritis by using an expression plasmid for the soluble p75 tumor necrosis factor receptor-Fc fusion protein
J-M Kim, S-H Ho, W Hahn, et al.
Agents and Actions
|
January 1, 1993
The design and synthesis of second generation leukotriene B4 (LTB4) receptor antagonists related to SC-41930
T D Penning, S W Djuric, S H Docter, et al.
Mayo Clinic Proceedings
|
November 24, 1999
Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial
W G Bensen, J J Fiechtner, J I McMillen, et al.
JAMA
|
December 2, 1999
Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial
L S Simon, A L Weaver, D Y Graham, et al.
Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics
|
January 23, 2025
[Short-term efficacy of rituximab in children with calcineurin inhibitor resistant steroid resistant nephrotic syndrome]
S S Yu, J L Liu, J J Liu, et al.
Physical Review Letters
|
December 31, 2005
Drift compression of an intense neutralized ion beam
P K Roy, S S Yu, E Henestroza, et al.
Journal of Medicinal Chemistry
|
April 25, 1997
Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib)
T D Penning, J J Talley, S R Bertenshaw, et al.
Page
of 57